Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016809
Chunk: 103

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 103
---
 issued in the private placement at an exercise price of $53,600.00 per warrant, and (4) 62,184,525 Ordinary Shares represented by 621 Depositary Shares, issuable upon the exercise of pre-funded warrants issued in the private placement at an exercise price of $8.00 per warrant, for aggregate gross proceeds of approximately $6.0 million. We also issued unregistered placement agent warrants to purchase a total of 500,000 Ordinary Shares represented by five Depositary Shares to Ladenburg Thalmann & Co. Inc ., or Ladenburg, at an exercise price of $ $58,000.00 per warrant, and Series A Warrants to purchase 625,000 Ordinary Shares represented by six Depositary Shares at an exercise price of $53,600.00 per warrant to an investor pursuant to a waiver.

On May 26, 2023, in a private placement
with certain institutional investors, we sold (1) 166,017,700 Ordinary Shares represented by 1,660 Depositary Shares, issuable upon the
exercise of the Series C Warrants at an exercise price of $4,000.00 per warrant, (2) 110,675,600 Ordinary Shares represented 1,098 Depositary
Shares issuable upon the exercise of the Series D Warrants at an exercise price of $4,000.00 per warrant and, (3) 4,426,800 Ordinary
Shares represented by 44 Depositary Shares issuable upon the exercise of the May 2023 Placement Agent Warrants at an exercise price of
$3,750.00 per warrant.

On December 21, 2023, in two private
placement transactions, we issued (i) an aggregate of 899 Depositary Shares to certain secured noteholders of Adhera Therapeutics, Inc.,
and (y) an aggregate of 9,098 pre-funded warrants to purchase Depositary Shares to certain of the secured noteholders, and (ii) issued
to Melior 1,417 of our Depositary Shares.

On February 26, 2024, in connection
with our Company’s obligations under a license agreement with Melior, we issued 1,417 Depositary Shares to Bukwang.

On April 29, 2024, in connection with
the closing of a license agreement, we issued 1,512 Depositary Shares to Emtora.

On May 24, 2024, in connection with